Pediatrix Medical Group (NYSE:MD) Shares Gap Down – What’s Next?

Shares of Pediatrix Medical Group, Inc. (NYSE:MD) gapped down prior to trading on Monday . The stock had previously closed at $26.61, but opened at $25.33. Pediatrix Medical Group shares last traded at $26.4640, with a volume of 14,790 shares trading hands.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on MD shares. UBS Group increased their price objective on shares of Pediatrix Medical Group from $25.00 to $28.00 and gave the stock a “neutral” rating in a research note on Thursday, August 6th. Truist Financial boosted their target price on shares of Pediatrix Medical Group from $23.00 to $28.00 and gave the company a “hold” rating in a research report on Tuesday, July 14th. Jefferies Financial Group downgraded shares of Pediatrix Medical Group from a “buy” rating to a “hold” rating and upped their price target for the stock from $27.00 to $28.00 in a report on Wednesday, August 19th. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and set a $25.00 target price on shares of Pediatrix Medical Group in a research note on Wednesday, August 5th. Finally, Mizuho set a $24.00 price target on shares of Pediatrix Medical Group in a report on Friday, May 8th. Seven research analysts have rated the stock with a Hold rating, According to data from MarketBeat, Pediatrix Medical Group has a consensus rating of “Hold” and an average target price of $25.00.

Pediatrix Medical Group Stock Up 1.0%

The company has a market cap of $2.15 billion, a price-to-earnings ratio of 12.67 and a beta of 0.64. The stock’s 50-day moving average is $26.17 and its 200-day moving average is $23.26. The company has a current ratio of 1.32, a quick ratio of 1.32 and a debt-to-equity ratio of 0.45.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings results on Tuesday, August 4th. The company reported $0.63 earnings per share for the quarter, beating the consensus estimate of $0.59 by $0.04. The firm had revenue of $487.78 million during the quarter, compared to the consensus estimate of $478.49 million. Pediatrix Medical Group had a net margin of 8.96% and a return on equity of 20.05%. The business’s revenue was up 4.1% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.53 earnings per share. On average, analysts anticipate that Pediatrix Medical Group, Inc. will post 2.17 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Pediatrix Medical Group

Hedge funds and other institutional investors have recently modified their holdings of the company. Keybank National Association OH lifted its holdings in shares of Pediatrix Medical Group by 2.0% in the 1st quarter. Keybank National Association OH now owns 22,941 shares of the company’s stock worth $491,000 after purchasing an additional 458 shares in the last quarter. Gotham Asset Management LLC increased its stake in Pediatrix Medical Group by 0.6% during the 3rd quarter. Gotham Asset Management LLC now owns 116,093 shares of the company’s stock valued at $1,945,000 after purchasing an additional 724 shares in the last quarter. ProShare Advisors LLC increased its stake in Pediatrix Medical Group by 4.6% during the 4th quarter. ProShare Advisors LLC now owns 16,816 shares of the company’s stock valued at $360,000 after purchasing an additional 734 shares in the last quarter. Verition Fund Management LLC raised its holdings in Pediatrix Medical Group by 4.4% during the third quarter. Verition Fund Management LLC now owns 25,408 shares of the company’s stock worth $426,000 after buying an additional 1,066 shares during the last quarter. Finally, Concurrent Investment Advisors LLC raised its holdings in Pediatrix Medical Group by 4.0% during the second quarter. Concurrent Investment Advisors LLC now owns 28,384 shares of the company’s stock worth $719,000 after buying an additional 1,087 shares during the last quarter. Institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc (NYSE:MD) is a national physician-led medical group specializing in high-acuity newborn, maternal-fetal and pediatric subspecialty care. Headquartered in Sunrise, Florida, the company delivers clinical services through hospital-based physician staffing, advanced practitioner support and telemedicine programs. Its core specialties include neonatology, maternal-fetal medicine, pediatric cardiology, pediatric critical care, pediatric emergency medicine and anesthesiology.

Founded in 1979 and formerly known as MEDNAX, the company rebranded as Pediatrix Medical Group in 2022 to align its corporate identity with its primary clinical offerings.